Am J Transplant, Volume 19, Suppl 3 Archives - Page 197 of 214 - ATC Abstracts

2019 American Transplant Congress
Pediatric Liver Retransplantation: Prognostic Scoring Tool
A. Kuhne, D. Vock, J. Back, K. Ramanathan, A. Matas, S. Chinnakotla
University of Minnesota Medical School, Minneapolis, MN
*Purpose: Liver Re-transplantation is the only option for survival when a transplanted liver fails. However, Re-transplantion of the liver remains a challenge given the scarcity…
2019 American Transplant Congress
Unos Analysis Of Deceased Donor Renal Transplant (ddrtx) Outcomes In Sensitized Patients After Implementation Of The Kidney Allocation System (kas)
R. J. Crew, K. L. King, M. Fajardo, J. Hedvat, N. Lange, S. Husain, S. Mohan, L. E. Ratner, S. S. Patel
Columbia University Irving Medical Center, New York, NY
*Purpose: Introduction of KAS in 2014 prioritized access to DDRTx for highly-sensitized candidates although it was unclear whether the outcomes would be acceptable in this…
2019 American Transplant Congress
The Implementation and Impact of an Opioid Minimization Protocol in an Urban Renal Transplant Population
A. Lichvar, M. Campara, E. Benedetti, J. Benken
University of Illinois at Chicago, Chicago, IL
*Purpose: The opioid epidemic within the United States has devastated patients and their families in addition to triggering a national public health crisis. Unnecessary prescribing…
2019 American Transplant Congress
Donor Safety for Minimal Invasive Hepatectoy in Liver Transplantation: The Korean Organ Transplantation Registry
H. Yu, J. Yang, S. Ahn
Chonbuk National University Hospital, Jeonju, Korea, Republic of
*Purpose: This study evaluated the safety and effectiveness of minimal invasive living donor hepatectomy in comparison with conventional open procedure using Korean Organ Transplantation Registry…
2019 American Transplant Congress
Integrated Analysis of Messenger RNA and Micro RNA Profiles in Fatty Liver Donors: Molecular Networks during Ischemia Reperfusion Injury
D. Maluf¹, A. Bajwa¹, S. K. Satapathy², V. Sai Bontha¹, A. Kadimella¹, J. Eason³, V. Mas⁴
¹UTHSC, Memphis, TN, ²UTHSC, memphis, TN, ³Director of Transplant Institute - UTHSC, Memphis, TN, ⁴Director of Transplant Research Institute, Memphis, TN
*Purpose: Liver steatosis is a known risk factor for exacerbated ischemia-reperfusion injury (IRI) and poor outcomes after liver transplantation (LT). RNA profiling was performed to…
2019 American Transplant Congress
Urinary Cell mRNA Sequencing Profiles of Kidney Allograft Recipients Mirror Intragraft Events and Demonstrate Enrichment for Immune Cells
M. Lubetzky¹, A. Verma², H. Yang¹, T. Muthukumar¹, S. Salvatore¹, J. Lee¹, D. Dadhania¹, S. Seshan¹, F. Mueller¹, O. Elemento², M. Suthanthiran¹
¹Division of Nephrology, Weill Cornell, New York, NY, ²Institute for Computational Biomedicine, Weill Cornell, New York, NY
*Purpose: Urinary cell mRNA profiling to interrogate kidney allograft status is based on the premise that the allograft can function as an in-vivo flow cytometer…
2019 American Transplant Congress
A Randomized, Controlled, Trial of Interventions to Promote Walking after Abdominal Organ Transplantation: The LIFT Study
M. Serper¹, I. Barankay², S. Chadha¹, J. Shults³, P. Reese¹
¹University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, ²Wharton School, University of Pennsylvania, Philadelphia, PA, ³Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA
*Purpose: Substantial weight gain and sedentary behavior are common after transplantation. Behavioral economic strategies with financial incentives and reminders may promote healthy behaviors in the…
2019 American Transplant Congress
A National Survey of Immunosuppression Strategies in Intestinal Transplantation
M. Segovia¹, T. Beduschi², J. Boike³, D. Farmer⁴, S. Horslen⁵, K. Iyer⁶, S. Jafri⁷, A. Langnas⁸, C. Matsumoto⁹, A. Mavis¹, G. Mazariegos¹⁰, S. Nagai⁷, J. O'Leary¹¹, Y. Patel¹, D. Sudan¹, N. Sulejmani⁷, B. Summers⁷, T. Schiano⁶
¹Duke, Durham, NC, ²Univ Miami, Miami, FL, ³NWU, Chicago, IL, ⁴UCLA, Los Angeles, CA, ⁵Seattle Child, Seattle, WA, ⁶Mt Sinai, NY, NY, ⁷Henry Ford, Detroit, MI, ⁸UNMC, Omaha, NE, ⁹Georgetown, Washington, DC, ¹⁰UPMC, Pittsburgh, PA, ¹¹Dallas VAMC, Dallas, TX
*Purpose: Review the management of immunosuppression (IS) for intestinal transplantation (IT) in the USA*Methods: A survey was created and sent via email to surgical directors…
2019 American Transplant Congress
Increasing Net Immunosuppression after BK Viremia
L. Cotiguala, A. Masood, J. Park, A. Naik
University of Michigan, Ann Arbor, MI
*Purpose: BK viremia is associated with inferior kidney allograft outcomes. Typical treatment involves reduction in immunosuppression. However reduction in immunosuppression is also likely to lead…
2019 American Transplant Congress
Recipients with Model for End-Stage Liver Disease Sodium Score Driven by Renal Dysfunction Have Increased Post-Transplant Mortality
T. Bittermann, D. Goldberg
Gastroenterology, University of Pennsylvania, Philadelphia, PA
*Purpose: Since the adoption of the Model for End-stage Liver Disease (MELD) score as a primary means of waitlist prioritization for liver transplantation (LT), an…